サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1770161

合成生物学の世界市場

Synthetic Biology

出版日
ページ情報
英文 442 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.42円
合成生物学の世界市場
出版日: 2025年07月14日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 442 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

合成生物学の世界市場は2030年までに862億米ドルに達する見込み

2024年に197億米ドルと推定された合成生物学の世界市場は、2024～2030年の分析期間においてCAGR 27.9%で成長し、2030年には862億米ドルに達すると予想されます。本レポートで分析したセグメントの1つであるオリゴヌクレオチド・合成DNAは、CAGR 29.1％を記録し、分析期間終了までに395億米ドルに達すると予想されます。酵素分野の成長率は、分析期間中CAGR 26.8％と推定されます。

米国市場は69億米ドルと推定される一方、中国はCAGR 32.0%で成長すると予測される

米国の合成生物学市場は2024年に69億米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 32.0%を牽引し、2030年までに89億米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ25.7%と26.6%と予測されています。欧州では、ドイツがCAGR 28.6%で成長すると予測されています。

世界の合成生物学市場- 主要動向と促進要因のまとめ

合成生物学は、工学、生物学、化学、コンピューターサイエンス、遺伝学の原理を組み合わせて、新しい生物学的部品、装置、システムを設計・構築する学際的な科学の一分野です。この分野は、既存の自然の生物学的システムを有用な目的のために再設計し、所望の機能を持つ新規の生物を工学的に設計することを目的としています。その中核となる合成生物学では、遺伝物質を合成して自然界には存在しないDNA配列を作成し、それを用いて生物に特定のタスクを実行させるようプログラムします。その応用範囲は、バイオ燃料や医薬品の生産から、新素材の創製や生物学的情報処理まで多岐にわたる。

合成生物学の分野は、CRISPR-Cas9のような遺伝子工学技術の進歩により、ゲノム編集の精度、効率、価格が飛躍的に向上し、大きな進歩を遂げました。さらに、合成生物学は、遺伝子変異のハイスループット合成と試験を可能にする自動化されたコンピューター支援技術に依存することが多いです。このような能力は、健康、エネルギー、環境管理などの問題に対する生物学的解決策の開発を急速に進展させる。例えば、合成生物学者たちは、マラリア治療用のアルテミシニンのような複雑な薬剤を生産できる酵母細胞や、プラスチックを分解して環境に優しい製品別に変えることができるバクテリアを操作してきました。人工知能や機械学習と合成生物学の融合もまた、新たな発見や応用を解き放ち、実現可能なことの限界をさらに押し広げる可能性を秘めています。

合成生物学市場の成長は、様々な産業における持続可能なソリューションへの需要の高まり、バイオテクノロジー応用の拡大、研究開発への多額の投資など、いくつかの要因によって牽引されています。環境問題への懸念と持続可能な生産方法の必要性が、バイオベースの化学物質、材料、燃料の開発における合成生物学の利用を後押ししています。このアプローチはエコロジカル・フットプリントの削減に役立つだけでなく、化石燃料への依存を減らすことにもつながります。医薬品分野では、従来の創薬プロセスでは時間とコストがかかるため、より効果的な新しい治療法を生み出すために合成生物学の技術が利用されています。また、バイオテクノロジーの進歩を支援する政策的枠組みや、学際的な科学に長けた労働力の増加も市場を後押ししています。ベンチャーキャピタルからの資金提供や政府からの助成金などの経済的要因も、この分野に資金を投入し続け、革新的な新興企業の立ち上げやバイオテクノロジーによる解決策の規模拡大を促進しています。このように、合成生物学が材料、化学物質、医薬品の開発方法を変革し、効率、コスト、性能の大幅な向上をもたらすことから、市場は力強い成長が見込まれています。

セグメント

ツール（オリゴヌクレオチド・合成DNA、酵素、クローニング技術キット、合成細胞、ゼノ核酸（XNA）、シャーシ生物）、技術（ヌクレオチド合成・シーケンス、ゲノム工学、マイクロ流体工学、その他技術）、用途（医薬品・診断薬、産業、食品・農業、環境、その他用途）

調査対象企業の例

  • Agilent Technologies, Inc.
  • Amyris, Inc.
  • Agrivida, Inc.
  • ATG Biosynthetics GmbH
  • Algentech SAS
  • Arzeda
  • AdvanceSyn
  • Asimov, Inc.
  • ArsenalBio
  • Abiochem Biotechnology
  • Accelerbiotics
  • Antheia
  • Ardra Bio
  • Baccuico
  • Absci Corp.

AIインテグレイションズ

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP-6581

Global Synthetic Biology Market to Reach US$86.2 Billion by 2030

The global market for Synthetic Biology estimated at US$19.7 Billion in the year 2024, is expected to reach US$86.2 Billion by 2030, growing at a CAGR of 27.9% over the analysis period 2024-2030. Oligonucleotides & Synthetic DNA, one of the segments analyzed in the report, is expected to record a 29.1% CAGR and reach US$39.5 Billion by the end of the analysis period. Growth in the Enzymes segment is estimated at 26.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.9 Billion While China is Forecast to Grow at 32.0% CAGR

The Synthetic Biology market in the U.S. is estimated at US$6.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$8.9 Billion by the year 2030 trailing a CAGR of 32.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 25.7% and 26.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 28.6% CAGR.

Global Synthetic Biology Market - Key Trends & Drivers Summarized

Synthetic biology is an interdisciplinary branch of science that combines principles from engineering, biology, chemistry, computer science, and genetics to design and construct new biological parts, devices, and systems. This field aims to redesign existing natural biological systems for useful purposes and to engineer novel organisms with desired functions. At its core, synthetic biology involves the synthesis of genetic material to create DNA sequences that do not exist in the natural world, which are then used to program organisms to perform specific tasks. Applications range from producing biofuels and pharmaceuticals to creating new materials and processing information biologically.

The field of synthetic biology has made significant strides thanks to advancements in genetic engineering techniques such as CRISPR-Cas9, which have dramatically increased the precision, efficiency, and affordability of genome editing. Moreover, synthetic biology often relies on automated and computer-assisted techniques that allow for the high-throughput synthesis and testing of genetic variations. These capabilities facilitate rapid progress in developing biological solutions to issues in health, energy, and environmental management. For instance, synthetic biologists have engineered yeast cells that can produce complex drugs, like artemisinin for malaria treatment, and bacteria that can break down plastics into environmentally benign byproducts. The integration of artificial intelligence and machine learning with synthetic biology also holds the potential to unlock new discoveries and applications, further pushing the boundaries of what can be achieved.

The growth in the synthetic biology market is driven by several factors, including the increasing demand for sustainable solutions across various industries, the expansion of biotechnology applications, and significant investment in research and development. Environmental concerns and the need for sustainable production methods propel the use of synthetic biology in developing bio-based chemicals, materials, and fuels. This approach not only helps in reducing the ecological footprint but also in diminishing dependence on fossil fuels. In the pharmaceutical sector, synthetic biology techniques are being used to produce new and more effective therapies, especially as traditional drug discovery processes prove to be time-consuming and costly. The market is also bolstered by policy frameworks that support biotechnological advancements and by a growing workforce skilled in interdisciplinary sciences. Economic factors, including venture capital funding and governmental grants, continue to inject financial resources into the field, promoting innovative startups and scaling up of bio-engineered solutions. As such, the market is expected to see robust growth as synthetic biology transforms how materials, chemicals, and drugs are developed, offering vast improvements in efficiency, cost, and performance.

SCOPE OF STUDY:

The report analyzes the Synthetic Biology market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Tool (Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA), Chassis Organism); Technology (Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics, Other Technologies); Application (Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental, Other Applications)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Rest of Europe; Asia-Pacific; Rest of World.

Select Competitors (Total 141 Featured) -

  • Agilent Technologies, Inc.
  • Amyris, Inc.
  • Agrivida, Inc.
  • ATG Biosynthetics GmbH
  • Algentech SAS
  • Arzeda
  • AdvanceSyn
  • Asimov, Inc.
  • ArsenalBio
  • Abiochem Biotechnology
  • Accelerbiotics
  • Antheia
  • Ardra Bio
  • Baccuico
  • Absci Corp.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Synthetic Biology - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Synthetic Biology - A New Interdisciplinary Field
    • Growing Importance of Synthetic Biology
    • Applications of Synthetic Biology
    • Synthetic Biology Tools
    • Technologies Involved
    • Market Outlook
    • Regional Landscape
    • Major Challenges and Concerns
    • Teaming R&D Funding & Potential to Alter Molecular Landscape Enable Global Synthetic Biology Market to Remain in High Spirits
    • Synthetic Biology to Radically Change the World for Good with Endless Applications
    • Competitive Landscape
    • Major Players by Industry Verticals
    • Select Market Participants
    • Synthetic Biology Startups Get Aggressive on Bioengineered Product Commercialization
    • Compelling Breakthroughs Drive Funding
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Synthetic Biology Market Witnesses Significant Rise in Investments
    • Importance of Synthetic Biology for Investments
    • Efforts from Leading Players Bodes Well for Market Growth
    • Patent Landscape Gets Richer
    • Robotics and Workflow Automation Support Market Expansion
    • Advancements in Instrumentation Augurs Well
    • Improvements in Computer-Aided Biology
    • Fusion of AI and Synthetic Biology Expands Opportunities
    • Synthetic Biology Brings a Paradigm Shift in the Field of Biological Research
    • DNA Sequencing Plays an Important Role
    • Plummeting Cost of DNA Sequencing Bolsters Market Growth
    • Food Scarcity to Fuel Synthetic Biology Application in Agriculture
    • Select Companies Engaged in Making Food Using Synthetic Biology
    • Synthetic Biology Aids in Development of Exotic and Artificially Grown Meats and Proteins to Meet Future Food Demand
    • Growing Demand for GM Crops Opens Up Growth Avenues
    • Synthetic Biology-based Ingredients Gain Traction
    • Role of Synthetic Biology in Producing Plants with Desirable Characteristics
    • Synthetic Biology Gains Prominence in Biomedical Applications
    • Synthetic Genes Open up a New World of Drug Development
    • Synthetic Biology to Transform Healthcare with Captivating Advances in Biomedicine
    • Synthetic Biology Enables Creation of Advanced Biosensing Systems
    • Synthetic Biology Gains Significance in Production of Bio-Based Chemicals and Biofuels
    • Global Biofuels Market in US$ Billion: 2019 and 2024
    • Synthetic Biology Gains Importance as Focus on Carbon Recycling Increases
    • Synthetic Biology Disrupts the Cosmetics Sector
    • Capability of Synthetic Biology in Environmental Applications
    • Synthetic Biology Creates Buzz as Key Enabler of Exciting & Dynamic Applications for Diverse Domains
    • Synthetic Biology for Advanced, Multifunctional Materials
    • Genetically Engineered Fabrics and Sustainable Dyes Using Synthetic Biology to Transform Textile Industry
    • Select Synthetic Biology Offerings in Textile Industry
    • Personalized Medicine to Display Notable Leap Forward with Synthetic Biology
    • 3D Bio-Printing
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Synthetic Biology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Synthetic Biology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Synthetic Biology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Oligonucleotides & Synthetic DNA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Oligonucleotides & Synthetic DNA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Oligonucleotides & Synthetic DNA by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Enzymes by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Cloning Technology Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Cloning Technology Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Cloning Technology Kits by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Synthetic Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Synthetic Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Synthetic Cells by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Xeno-Nucleic Acids (XNA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Xeno-Nucleic Acids (XNA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Xeno-Nucleic Acids (XNA) by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Chassis Organism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Chassis Organism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Chassis Organism by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Nucleotide Synthesis & Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Nucleotide Synthesis & Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Nucleotide Synthesis & Sequencing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Genome Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Genome Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for Genome Engineering by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Microfluidics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Microfluidics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 30: World 15-Year Perspective for Microfluidics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 33: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Pharmaceuticals & Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Pharmaceuticals & Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 36: World 15-Year Perspective for Pharmaceuticals & Diagnostics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 37: World Recent Past, Current & Future Analysis for Industrial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 38: World Historic Review for Industrial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 39: World 15-Year Perspective for Industrial by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 40: World Recent Past, Current & Future Analysis for Food & Agriculture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 41: World Historic Review for Food & Agriculture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 42: World 15-Year Perspective for Food & Agriculture by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 43: World Recent Past, Current & Future Analysis for Environmental by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 44: World Historic Review for Environmental by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 45: World 15-Year Perspective for Environmental by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 46: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 47: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 48: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 49: World Synthetic Biology Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Synthetic Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 50: USA Recent Past, Current & Future Analysis for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Synthetic Biology by Tool - Percentage Breakdown of Value Revenues for Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the Years 2015, 2025 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: USA 15-Year Perspective for Synthetic Biology by Technology - Percentage Breakdown of Value Revenues for Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 56: USA Recent Past, Current & Future Analysis for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: USA Historic Review for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: USA 15-Year Perspective for Synthetic Biology by Application - Percentage Breakdown of Value Revenues for Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Synthetic Biology by Tool - Percentage Breakdown of Value Revenues for Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the Years 2015, 2025 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Canada 15-Year Perspective for Synthetic Biology by Technology - Percentage Breakdown of Value Revenues for Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 65: Canada Recent Past, Current & Future Analysis for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Canada Historic Review for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Canada 15-Year Perspective for Synthetic Biology by Application - Percentage Breakdown of Value Revenues for Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Synthetic Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Synthetic Biology by Tool - Percentage Breakdown of Value Revenues for Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the Years 2015, 2025 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Japan 15-Year Perspective for Synthetic Biology by Technology - Percentage Breakdown of Value Revenues for Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 74: Japan Recent Past, Current & Future Analysis for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Japan 15-Year Perspective for Synthetic Biology by Application - Percentage Breakdown of Value Revenues for Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Synthetic Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 77: China Recent Past, Current & Future Analysis for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Synthetic Biology by Tool - Percentage Breakdown of Value Revenues for Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the Years 2015, 2025 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Synthetic Biology by Technology - Percentage Breakdown of Value Revenues for Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: China Historic Review for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: China 15-Year Perspective for Synthetic Biology by Application - Percentage Breakdown of Value Revenues for Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Synthetic Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Synthetic Biology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Synthetic Biology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Synthetic Biology by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Synthetic Biology by Tool - Percentage Breakdown of Value Revenues for Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the Years 2015, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Synthetic Biology by Technology - Percentage Breakdown of Value Revenues for Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for Synthetic Biology by Application - Percentage Breakdown of Value Revenues for Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Synthetic Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 98: France Recent Past, Current & Future Analysis for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: France 15-Year Perspective for Synthetic Biology by Tool - Percentage Breakdown of Value Revenues for Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the Years 2015, 2025 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: France 15-Year Perspective for Synthetic Biology by Technology - Percentage Breakdown of Value Revenues for Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 104: France Recent Past, Current & Future Analysis for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: France Historic Review for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: France 15-Year Perspective for Synthetic Biology by Application - Percentage Breakdown of Value Revenues for Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Synthetic Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Germany 15-Year Perspective for Synthetic Biology by Tool - Percentage Breakdown of Value Revenues for Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the Years 2015, 2025 & 2030
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Germany 15-Year Perspective for Synthetic Biology by Technology - Percentage Breakdown of Value Revenues for Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 113: Germany Recent Past, Current & Future Analysis for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Germany Historic Review for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Germany 15-Year Perspective for Synthetic Biology by Application - Percentage Breakdown of Value Revenues for Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Italy 15-Year Perspective for Synthetic Biology by Tool - Percentage Breakdown of Value Revenues for Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the Years 2015, 2025 & 2030
    • TABLE 119: Italy Recent Past, Current & Future Analysis for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Italy Historic Review for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Italy 15-Year Perspective for Synthetic Biology by Technology - Percentage Breakdown of Value Revenues for Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 122: Italy Recent Past, Current & Future Analysis for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Italy Historic Review for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Italy 15-Year Perspective for Synthetic Biology by Application - Percentage Breakdown of Value Revenues for Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Synthetic Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 125: UK Recent Past, Current & Future Analysis for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: UK 15-Year Perspective for Synthetic Biology by Tool - Percentage Breakdown of Value Revenues for Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the Years 2015, 2025 & 2030
    • TABLE 128: UK Recent Past, Current & Future Analysis for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: UK Historic Review for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: UK 15-Year Perspective for Synthetic Biology by Technology - Percentage Breakdown of Value Revenues for Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 131: UK Recent Past, Current & Future Analysis for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: UK Historic Review for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: UK 15-Year Perspective for Synthetic Biology by Application - Percentage Breakdown of Value Revenues for Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Synthetic Biology by Tool - Percentage Breakdown of Value Revenues for Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Synthetic Biology by Technology - Percentage Breakdown of Value Revenues for Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Synthetic Biology by Application - Percentage Breakdown of Value Revenues for Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Synthetic Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Synthetic Biology by Tool - Percentage Breakdown of Value Revenues for Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Synthetic Biology by Technology - Percentage Breakdown of Value Revenues for Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Synthetic Biology by Application - Percentage Breakdown of Value Revenues for Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 152: Rest of World Recent Past, Current & Future Analysis for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of World Historic Review for Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of World 15-Year Perspective for Synthetic Biology by Tool - Percentage Breakdown of Value Revenues for Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the Years 2015, 2025 & 2030
    • TABLE 155: Rest of World Recent Past, Current & Future Analysis for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of World Historic Review for Synthetic Biology by Technology - Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of World 15-Year Perspective for Synthetic Biology by Technology - Percentage Breakdown of Value Revenues for Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of World Recent Past, Current & Future Analysis for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of World Historic Review for Synthetic Biology by Application - Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of World 15-Year Perspective for Synthetic Biology by Application - Percentage Breakdown of Value Revenues for Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION